Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX®

Study Identifier
GMA-CAN-NEU-0336
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Migraine - General
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years

    Protocol Summary

    This study will prospectively assess long term heath related quality of life in chronic migraine patients currently being treated with OnabotulinumtoxinA for injection (BOTOX®) as standard of care.

    Study Locations

    Location
    Status
    Location
    Foothills Medical Centre
    Calgary, Alberta, Canada, T2N 2T9
    Status
    Not applicable
    Location
    Hys Medical Centre
    Edmonton, Alberta, Canada, T5H 4B9
    Status
    Not applicable
    Location
    Bayside Medical Centre
    Brentwood Bay, British Columbia, Canada, V8M 1P6
    Status
    Not applicable
    Location
    Jeff Oyler
    Kamloops, British Columbia, Canada, V2C 5T1
    Status
    Not applicable
    Location
    Dhawan Medical Corporation Medical Clinic
    Vancouver, British Columbia, Canada, V5Z 4E1
    Status
    Not applicable
    Location
    May Ong-Lam
    Vancouver, British Columbia, Canada, V6Z 2E8
    Status
    Not applicable
    Showing {first} - {last} of {total} Results